123 related articles for article (PubMed ID: 12793384)
1. NCI study: more than 2 million U.S. women could benefit from tamoxifen.
FDA Consum; 2003; 37(3):7. PubMed ID: 12793384
[No Abstract] [Full Text] [Related]
2. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer prevention with tamoxifen.
Haden K; Santen R
Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
[No Abstract] [Full Text] [Related]
4. Tamoxifen and beyond.
Harv Womens Health Watch; 1998 Jun; 5(10):1. PubMed ID: 9663008
[No Abstract] [Full Text] [Related]
5. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
Reichert D; Illiger HJ
Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
[No Abstract] [Full Text] [Related]
6. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
7. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
Kondo M; Hoshi SL; Toi M
Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.
Isaacs C
Clin Adv Hematol Oncol; 2005 Dec; 3(12):913-4. PubMed ID: 16555431
[No Abstract] [Full Text] [Related]
9. Chemoprevention trends in breast cancer.
Lazzaro M; Mizell V; Thompson M; Weber D
Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
[No Abstract] [Full Text] [Related]
10. Breast cancer risk in primary care: implications for chemoprevention.
Lewis CL; Kinsinger LS; Harris RP; Schwartz RJ
Arch Intern Med; 2004 Sep; 164(17):1897-903. PubMed ID: 15451765
[TBL] [Abstract][Full Text] [Related]
11. [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
Eiermann W
MMW Fortschr Med; 2003 Dec; 145(50):8. PubMed ID: 14963963
[No Abstract] [Full Text] [Related]
12. Another view of tamoxifen.
Napoli M
Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
[No Abstract] [Full Text] [Related]
13. Continuation of the International Breast Cancer Intervention Study (IBIS).
Cuzick J
Eur J Cancer; 1998 Oct; 34(11):1647-8. PubMed ID: 9893646
[No Abstract] [Full Text] [Related]
14. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
[No Abstract] [Full Text] [Related]
15. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
Fabian C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
[No Abstract] [Full Text] [Related]
16. Tamoxifen. To take or not to take. That is the question.
Blanchard P
Tex Nurs; 1999 Aug; 73(7):4-5, 7. PubMed ID: 11949057
[No Abstract] [Full Text] [Related]
17. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
[TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U;
Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284
[TBL] [Abstract][Full Text] [Related]
19. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
[TBL] [Abstract][Full Text] [Related]
20. Cancer prevention or drug promotion? Journalists mishandle the tamoxifen story.
Poe A
Int J Health Serv; 1999; 29(3):657-61. PubMed ID: 10450552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
